An interesting european study where patients with heart failure were randomized to ecmo or not ecmo, with no significant difference
Studies like this are not often run in the us because there isnt a national health service which can facilitate this sort of trial, and no industry corporation has an incentive to run this either
So when dealing with very expensive complex treatments which sometimes seem to “work” impressively, remember that it may be completely useless
An interesting european study where patients with heart failure were randomized to ecmo or not ecmo, with no significant difference
Studies like this are not often run in the us because there isnt a national health service which can facilitate this sort of trial, and no industry corporation has an incentive to run this either
So when dealing with very expensive complex treatments which sometimes seem to “work” impressively, remember that it may be completely useless